Author(s): Khoirul Anam, Bobi Prabowo, Meike Tiya Kusuma, Yuliati, Sri Winarsih, Tri Yudani Mardining Raras, Sumarno Reto Prawiro
DOI: 10.52711/0974-360X.2022.00238
Views:
18
(pdf),
2786
(html)
Access:
Open Access
Cite: Khoirul Anam, Bobi Prabowo, Meike Tiya Kusuma, Yuliati, Sri Winarsih, Tri Yudani Mardining Raras, Sumarno Reto Prawiro. Multi Epitopes Potential on Surface SARS-CoV-2 Protein as a Covid-19 Vaccine Candidate. Research Journal of Pharmacy and Technology. 2022; 15(4):1437-2. doi: 10.52711/0974-360X.2022.00238
Read More
|
Author(s): Bobi Prabowo, Tri Yudani Mardining Raras, Maria Lucia Inge Lusida, Wisnu Barlianto, Hidayat Sujuti, Edi Mustamsir, Respati Suryanto Drajat, Sumarno Reto Prawiro
DOI: 10.52711/0974-360X.2023.00435
Views:
34
(pdf),
2361
(html)
Access:
Open Access
Cite: Bobi Prabowo, Tri Yudani Mardining Raras, Maria Lucia Inge Lusida, Wisnu Barlianto, Hidayat Sujuti, Edi Mustamsir, Respati Suryanto Drajat, Sumarno Reto Prawiro. Roles of Anti-Inflammatory Active Ingredients of Saussurea costus in Silico approach as Adjuvant Therapy in COVID-19 Cases. Research Journal of Pharmacy and Technology 2023; 16(6):2649-4. doi: 10.52711/0974-360X.2023.00435
Read More
|
Author(s): Ichsanto Permadi, Is Helianti, Soemarno Reto Prawiro, Tri Yudani Mardining Raras
DOI: 10.52711/0974-360X.2024.00208
Views:
2
(pdf),
1389
(html)
Access:
Open Access
Cite: Ichsanto Permadi, Is Helianti, Soemarno Reto Prawiro, Tri Yudani Mardining Raras. Isolation of yidRhv Gene from Hypervirulent Klebsiella pneumoniae Indonesia Strain and in silico study of Gene product. Research Journal of Pharmacy and Technology. 2024; 17(3):1324-1. doi: 10.52711/0974-360X.2024.00208
Read More
|
Author(s): Badrul Munir, Dewi Santosaningsih, Dwi Yuni Nur Hidayati, Tri Yudani Mardining Raras, Tommy A Nazwar, Sumarno Reto Prawiro
DOI: 10.52711/0974-360X.2024.00670
Views:
1
(pdf),
1176
(html)
Access:
Open Access
Cite: Badrul Munir, Dewi Santosaningsih, Dwi Yuni Nur Hidayati, Tri Yudani Mardining Raras, Tommy A Nazwar, Sumarno Reto Prawiro. Detection of Recombinant Antigen 38 and Epitope Antigen 38 Antibody as Humoral Immune Response of Tuberculosis as a New Marker of Tuberculous Meningitis. Research Journal of Pharmacy and Technology. 2024; 17(9):4337-2. doi: 10.52711/0974-360X.2024.00670
Read More
|